+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Piramal Enterprises Ltd (PEL) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 54 Pages
  • June 2023
  • GlobalData
  • ID: 4284761
Piramal Enterprises Ltd (PEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Piramal Enterprises Ltd (PEL), formerly Piramal Healthcare Ltd, is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, Phyto Medicines, Anesthesia, Orthopedic medicines, Halothane, Isoflurane, Sevoflurane, and other OTC related medicines. It also offers contract manufacturing and development services, pharma solutions, critical care solutions, imaging services, and other services such as fund management, and structured investments. The company serves life sciences, financial services, health care, specialty glass packaging, and real estate sectors. It operates in India Germany, Italy, the UK, France, Canada, the US and other countries. PEL is headquartered in Mumbai, Maharashtra, India.

Piramal Enterprises Ltd Key Recent Developments

  • Jun 07, 2023: Piramal Enterprises Releases Annual Report
  • Jun 06, 2023: Piramal Critical Care Appoints Jeffrey Hampton as President & Chief Operating Officer
  • May 24, 2023: Piramal Pharma Limited Announces Consolidated Results for Q4 and FY2023
  • May 05, 2023: Piramal Enterprises reports audited financial results for quarter and year ended March 31, 2023

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Piramal Enterprises Ltd - Key Facts
  • Piramal Enterprises Ltd - Key Employees
  • Piramal Enterprises Ltd - Key Employee Biographies
  • Piramal Enterprises Ltd - Major Products and Services
  • Piramal Enterprises Ltd - History
  • Piramal Enterprises Ltd - Company Statement
  • Piramal Enterprises Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Piramal Enterprises Ltd - Business Description
  • Piramal Enterprises Ltd - Corporate Strategy
  • Piramal Enterprises Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Piramal Enterprises Ltd - Strengths
  • Piramal Enterprises Ltd - Weaknesses
  • Piramal Enterprises Ltd - Opportunities
  • Piramal Enterprises Ltd - Threats
  • Piramal Enterprises Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Piramal Enterprises Ltd, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Jun 07, 2023: Piramal Enterprises Releases Annual Report
  • Jun 06, 2023: Piramal Critical Care Appoints Jeffrey Hampton as President & Chief Operating Officer
  • May 24, 2023: Piramal Pharma Limited Announces Consolidated Results for Q4 and FY2023
  • May 05, 2023: Piramal Enterprises reports audited financial results for quarter and year ended March 31, 2023
  • Feb 08, 2023: Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2023
  • Nov 09, 2022: Piramal Enterprises Announces Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2022
  • Sep 29, 2022: Piramal Pharma Appoints Vibha Paul Rishi as Non- Executive Director to its Board of Directors
  • Jul 29, 2022: Piramal Enterprises Announces Consolidated Results for Q1 FY2023
  • Jul 29, 2022: Piramal Enterprises Announces Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June, 2022
  • May 24, 2022: Piramal Pharma Solutions upgrades oral solid dose capabilities with new production block at Pithampur Site
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Piramal Enterprises Ltd, Key Facts
  • Piramal Enterprises Ltd, Key Employees
  • Piramal Enterprises Ltd, Key Employee Biographies
  • Piramal Enterprises Ltd, Major Products and Services
  • Piramal Enterprises Ltd, History
  • Piramal Enterprises Ltd, Subsidiaries
  • Piramal Enterprises Ltd, Joint Venture
  • Piramal Enterprises Ltd, Key Competitors
  • Piramal Enterprises Ltd, Ratios based on current share price
  • Piramal Enterprises Ltd, Annual Ratios
  • Piramal Enterprises Ltd, Interim Ratios
  • Piramal Enterprises Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Piramal Enterprises Ltd, Performance Chart (2019 - 2023)
  • Piramal Enterprises Ltd, Ratio Charts

Samples

Loading
LOADING...

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Lupin Ltd
  • Dr. Reddy's Laboratories Ltd
  • Aditya Birla Sun Life Insurance Company Limited
  • Biocon Ltd
  • Sun Pharmaceutical Industries Ltd
  • Cipla Ltd
  • GlaxoSmithKline Pharmaceuticals Ltd
  • Adani Capital Private Limited
  • Aditya Birla Sun Life Insurance Company Limited
  • Lupin Ltd
  • Sun Pharmaceutical Industries Ltd
  • Adani Capital Private Limited
  • GlaxoSmithKline Pharmaceuticals Ltd
  • Dr. Reddy's Laboratories Ltd
  • Biocon Ltd
  • Cipla Ltd